Bipartisan Drug Pricing Reform

Senators Susan Collins (R-Maine), Claire McCaskill (D-Missouri), and Debbie Stabenow (D-Michigan) championed the “Patient Right to Know Drug Prices Act” and “The Know the Lower Price Act.” The Patient Right to Know Drug Price Act bans the use of gag-clauses by pharmaceutical companies and PBMs used to keep pharmacists from advising their patients to lower priced options. The cost of healthcare has been on a disturbing upward trend and any business practice restricting peoples access to information which could help them save money is unacceptable. President Trump signed both bills into law on October 10, 2018.